파마리서치

214450KOSDAQView the 제약 sectorTheme Bio & healthcare

266,000KRWMarket close of 10/20 (Tue)

Down -4.14%-11,500KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)264,000KRWDown -0.75%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
273,500
High
277,500
Low
263,500
Day range
Day range low 263,500 high 277,500, open 273,500, close 266,000, previous close 277,500
Volume
4×10K shares
11.9B KRW 0.39× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 258,500 to 602,000 won, 2% up from the low

2% of the way up from the lowest close in 1 year (252 sessions) · -55.8% from the high

Something to check

1 to check: bigger daily move than usual

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveto check-4.14%-4.14%, 2.1× the usual (20-session average ±2.02%)
    That day -4.14% · usual ±2.02% · large-move threshold ±4.0%
  • Trading valueusual range0.4×11.9B KRW, 0.4× the 20-session average
    0.39× the 20-session average · check threshold 3×
  • Earningsusual range237.5B KRWOperating income over the last four quarters 237.5B KRWOperating income, 8 quarters

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+21.8B KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 26 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.